---
title: Quick Reference Cards – rTKA Anesthesia Pathways
version: 1.5
last-updated: 2025-12-14
---

# Quick Reference Cards  
Robot-Assisted Total Knee Arthroplasty (rTKA) – 2025  
**Print → laminate → place at anesthesia machine**

> **Educational Use Only (Non-Clinical Use).**  
> This card is an educational synthesis and **not** a guideline, order set, or medical advice. Medication selection and dosing must be individualized to patient physiology, comorbidities, monitoring strategy, and institutional policy under **supervision of a licensed attending anesthesiologist**. Do not use this material to provide patient care.

---

## Ketamine Guardrails (Patient Selection, Hemodynamics, and BIS/EEG)

Ketamine is presented as an **optional sub-anesthetic adjunct** for opioid-sparing analgesia (**not** a default primary induction agent). Effects are **context-dependent**.

**Use caution, reduce dose, or omit** ketamine bolus/infusion when any of the following are present:
- **Hemodynamic instability** or escalating vasopressor requirement; suspected catecholamine-depleted physiology
- **Frailty / advanced age** with limited physiologic reserve (higher ASA class)
- Clinically significant **tachyarrhythmia risk**
- Severe psychiatric disease with active psychosis (context-dependent)

**Depth monitoring caveat:** Ketamine may **increase BIS** despite adequate or deep hypnosis. Do **not** titrate hypnotics to BIS alone after ketamine; correlate with clinical signs and raw EEG when available.

---

# Pathway 1 — OFIA + ACB/IPACK (Preferred ERAS Pathway)

| Section | Quick Reference |
|-------|-----------------|
| **Pre-op** | • Acetaminophen **1 g PO**<br>• Celecoxib **400 mg PO** (or meloxicam 15 mg)<br>• Dexamethasone **8–10 mg IV**<br>• Scopolamine patch (high PONV risk)<br>• **Avoid gabapentinoids** |
| **Blocks (Pre-Induction)** | • **Midazolam 1–2 mg IV** (dose-reduce elderly/frail)<br>• **ACB:** 20–30 mL ropivacaine 0.2–0.25%<br>• **IPACK:** 20 mL ropivacaine 0.2–0.25%<br>• Max ropivacaine dose **~3 mg/kg**<br>• **20% lipid emulsion immediately available** |
| **Induction** | • Midazolam **0.5–1 mg IV** optional<br>• **Propofol 1.5–2 mg/kg IV (primary hypnotic)**<br>• Ketamine **0.2–0.5 mg/kg IV** optional adjunct (see guardrails)<br>• Rocuronium **0.6–1.0 mg/kg IV** |
| **Adjuncts** | • Magnesium **30–50 mg/kg IV** (avoid CrCl <30)<br>• Dexmedetomidine **0.2–0.7 mcg/kg/hr** (≤0.6 if elderly/frail; avoid large bolus loading)<br>• Ketamine infusion **0.1–0.2 mg/kg/hr** optional |
| **Maintenance** | • **Propofol TIVA 75–150 mcg/kg/min** **OR** **Sevoflurane 0.8–1.2 MAC** (often used in combination depending on workflow)<br>• Maintain **MAP ≥65 mmHg** (individualize for CAD/CVA disease) |
| **Emergence** | • Stop dexmedetomidine **10–15 min** prior (as tolerated)<br>• Stop ketamine at closure (if used)<br>• Ondansetron **4 mg IV**<br>• Sugammadex **2–4 mg/kg** per TOF |
| **PACU** | • Expected pain **0–3/10**<br>• Ketamine **0.1–0.15 mg/kg IV q10–15 min** ×3 max (if appropriate)<br>• Opioids only if inadequate |

---

# Pathway 2 — OFIA Block-Free

| Section | Quick Reference |
|-------|-----------------|
| **Pre-op** | Same as Pathway 1 |
| **Blocks** | None — document reason (anticoagulation, refusal, anatomy, workflow)<br>• Surgeon infiltration: 100–150 mL ropivacaine 0.2% (max **~3 mg/kg**) |
| **Induction** | • Midazolam **1–2 mg IV** (dose-reduce elderly/frail)<br>• **Propofol 1.5–2 mg/kg IV (primary hypnotic)**<br>• Ketamine **0.2–0.5 mg/kg IV** optional adjunct<br>• Rocuronium **0.6–1.0 mg/kg IV** |
| **Adjuncts / Maintenance** | • Magnesium **30–50 mg/kg IV**<br>• Dexmedetomidine **0.3–0.7 mcg/kg/hr** (≤0.6 elderly/frail)<br>• **Propofol TIVA 75–150 mcg/kg/min** **OR** **Sevoflurane 0.8–1.2 MAC**<br>• Ketamine infusion **0.1–0.25 mg/kg/hr** optional<br>• Optional lidocaine infusion per institutional policy |
| **Emergence** | • Stop dexmedetomidine **10–15 min** prior<br>• Ondansetron **4 mg IV**<br>• Sugammadex PRN |
| **PACU** | • Expected pain **3–6/10**<br>• Ketamine rescue as above<br>• Opioids only if inadequate |

---

# Pathway 3 — Conventional Opioid-Inclusive Anesthesia

| Section | Quick Reference |
|-------|-----------------|
| **Pre-op** | • Acetaminophen **1 g PO**<br>• Celecoxib **400 mg PO**<br>• Dexamethasone **8–10 mg IV**<br>• **Midazolam 1–2 mg IV** (dose-reduce elderly/frail)<br>• Continue home opioids if chronic user |
| **Induction** | • Midazolam **0.5–1 mg IV** optional<br>• **Propofol 1.5–2 mg/kg IV (primary hypnotic)**<br>• **Fentanyl 1–2 mcg/kg IV** OR **Hydromorphone 0.2–0.4 mg IV**<br>• Rocuronium **0.6–1.0 mg/kg IV** |
| **Maintenance** | • **Propofol TIVA 75–150 mcg/kg/min** **OR** **Sevoflurane 0.8–1.2 MAC** (commonly hybrid depending on PONV/emergence goals)<br>• Fentanyl **25–50 mcg IV boluses PRN**<br>• Dexmedetomidine **0.2–0.4 mcg/kg/hr** optional (dose-reduce elderly/frail) |
| **Emergence** | • Ondansetron **4 mg IV**<br>• Sugammadex as indicated<br>• Expect longer emergence in opioid-exposed, elderly, or OSA patients |
| **PACU** | • Expected pain **2–6/10**<br>• Hydromorphone **0.2 mg IV q10 min PRN**<br>• **Enhanced respiratory monitoring** |

---

# Universal Safety Reminders (All Pathways)

- **Propofol 1.5–2 mg/kg IV is the default induction hypnotic**
- **Propofol TIVA and sevoflurane are interchangeable or complementary maintenance strategies**
- **Dose-reduce sedatives in elderly/frail patients**
- **No gabapentinoids** in routine pathways
- **Magnesium contraindicated if CrCl <30 mL/min**
- **Dexmedetomidine bradycardia:** treat per local protocol (e.g., glycopyrrolate **0.2–0.4 mg IV**)
- **Track total local anesthetic dose**; LAST preparedness mandatory
- **Maintain MAP ≥65 mmHg**, individualized to comorbidities
- **Ketamine alters BIS** — interpret depth cautiously

---

**Print tip:** GitHub → Print → Save as PDF → fits on a two-sided pocket card.
